{"id":"https://openalex.org/W1985337271","doi":"https://doi.org/10.1021/jm00128a032","title":"The synthesis of acyclonucleoside hydroxamic acids as inhibitors of ribonucleotide reductase","display_name":"The synthesis of acyclonucleoside hydroxamic acids as inhibitors of ribonucleotide reductase","alternate_titles":[],"publication_year":1989,"publication_date":"1989-08-01","ids":{"openalex":"https://openalex.org/W1985337271","doi":"https://doi.org/10.1021/jm00128a032","mag":"1985337271","pmid":"https://pubmed.ncbi.nlm.nih.gov/2666666"},"language":"en","primary_location":{"id":"doi:10.1021/jm00128a032","doi":"https://doi.org/10.1021/jm00128a032","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm00128a032","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1985337271"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064792064","display_name":"Robert A. Farr","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert A. Farr","raw_affiliation_strings":["Merrell Dow Research Institute, Cincinnati, Ohio 45215"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merrell Dow Research Institute, Cincinnati, Ohio 45215","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109311559","display_name":"Philippe Bey","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Philippe Bey","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111948091","display_name":"Prasad S. Sunkara","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Prasad S. Sunkara","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5054324911","display_name":"Bruce J. Lippert","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bruce J. Lippert","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":0.9554,"has_fulltext":false,"cited_by_count":19,"citation_normalized_percentile":{"value":0.64470017,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"32","issue":"8","first_page":"1879","last_page":"1885"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.4083999991416931,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.4083999991416931,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12827","display_name":"Biochemical and Molecular Research","score":0.23469999432563782,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.21799999475479126,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ribonucleotide-reductase-inhibitors","display_name":"ribonucleotide reductase inhibitors","score":0.9229999780654907},{"id":"https://openalex.org/keywords/ribonucleotide-reductase","display_name":"ribonucleotide reductase","score":0.8999999761581421},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.8569999933242798},{"id":"https://openalex.org/keywords/hydroxylamine","display_name":"hydroxylamine","score":0.6850000023841858},{"id":"https://openalex.org/keywords/5-fluorouracil-derivatives","display_name":"5-fluorouracil derivatives","score":0.8629999756813049},{"id":"https://openalex.org/keywords/hela-cells","display_name":"HeLa cells","score":0.7200000286102295}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9269420504570007},{"id":"https://openalex.org/C4710235","wikidata":"https://www.wikidata.org/wiki/Q420089","display_name":"Ribonucleotide reductase","level":4,"score":0.9191017150878906},{"id":"https://openalex.org/C2776730177","wikidata":"https://www.wikidata.org/wiki/Q421721","display_name":"Acetamide","level":2,"score":0.6682776212692261},{"id":"https://openalex.org/C2781184954","wikidata":"https://www.wikidata.org/wiki/Q422538","display_name":"Cytidine","level":3,"score":0.6173389554023743},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.5868362188339233},{"id":"https://openalex.org/C2775999725","wikidata":"https://www.wikidata.org/wiki/Q259997","display_name":"Hydroxylamine","level":2,"score":0.5472226142883301},{"id":"https://openalex.org/C98892162","wikidata":"https://www.wikidata.org/wiki/Q422484","display_name":"Ribonucleotide","level":4,"score":0.5271745920181274},{"id":"https://openalex.org/C2776281265","wikidata":"https://www.wikidata.org/wiki/Q420327","display_name":"Hydroxamic acid","level":2,"score":0.49466750025749207},{"id":"https://openalex.org/C2777995097","wikidata":"https://www.wikidata.org/wiki/Q422462","display_name":"Guanosine","level":2,"score":0.49325793981552124},{"id":"https://openalex.org/C2776844798","wikidata":"https://www.wikidata.org/wiki/Q34402","display_name":"Ribonucleoside","level":4,"score":0.4534062445163727},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.4144919216632843},{"id":"https://openalex.org/C114373084","wikidata":"https://www.wikidata.org/wiki/Q273499","display_name":"Chemical synthesis","level":3,"score":0.41162610054016113},{"id":"https://openalex.org/C512185932","wikidata":"https://www.wikidata.org/wiki/Q28745","display_name":"Nucleotide","level":3,"score":0.3973536491394043},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3574724793434143},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2300506830215454},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.15421533584594727},{"id":"https://openalex.org/C104292427","wikidata":"https://www.wikidata.org/wiki/Q899781","display_name":"Protein subunit","level":3,"score":0.0},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002621","descriptor_name":"Chemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006367","descriptor_name":"HeLa Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006877","descriptor_name":"Hydroxamic Acids","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D006877","descriptor_name":"Hydroxamic Acids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009705","descriptor_name":"Nucleosides","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D009705","descriptor_name":"Nucleosides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D012262","descriptor_name":"Ribonucleoside Diphosphate Reductase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D012264","descriptor_name":"Ribonucleotide Reductases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D055598","descriptor_name":"Chemical Phenomena","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/jm00128a032","doi":"https://doi.org/10.1021/jm00128a032","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm00128a032","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:2666666","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2666666","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.5683000087738037,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2046230345","https://openalex.org/W81587675","https://openalex.org/W2950557334","https://openalex.org/W1596026758","https://openalex.org/W2067430655","https://openalex.org/W2056217301","https://openalex.org/W2020909609","https://openalex.org/W4236411872","https://openalex.org/W2024825275","https://openalex.org/W4253133536"],"abstract_inverted_index":{"N-Hydroxy-alpha-(2-hydroxyethoxy)-1(2H)-pyrimidineacetamides":[0],"1-3":[1,78],"were":[2,25,60,79],"synthesized":[3,61],"as":[4],"potential":[5],"antitumor":[6],"agents":[7],"whose":[8],"mechanism":[9],"of":[10,15,33,51,65,103,119],"action":[11],"would":[12],"involve":[13],"inhibition":[14],"ribonucleoside":[16],"diphosphate":[17,89],"reductase":[18],"(RDPR,":[19],"EC":[20],"1.17.4.1).":[21],"Acyclonucleoside":[22],"esters":[23],"6-8":[24],"prepared":[26],"by":[27,62],"the":[28,45,63,101],"stannic":[29],"chloride":[30],"catalyzed":[31],"reaction":[32,64],"methyl":[34],"chloro[2-(phenylmethoxy)ethoxy]acetate":[35],"(5)":[36],"with":[37,71,97],"various":[38],"silylated":[39],"pyrimidines,":[40],"generated":[41],"in":[42,99],"situ":[43],"from":[44],"bases":[46],"and":[47,58,68,113],"bis(trimethylsilyl)acetamide.":[48],"Catalytic":[49],"didebenzylation":[50],"hydroxamate":[52],"11":[53],"gave":[54],"1,":[55],"while":[56,106],"2":[57,93],"3":[59,116],"lactones":[66],"14":[67],"22,":[69],"respectively,":[70],"hydroxylamine.":[72],"In":[73],"vitro":[74],"acyclonucleoside":[75],"hydroxamic":[76],"acids":[77],"3-10-fold":[80],"less":[81],"potent":[82],"than":[83],"hydroxyurea":[84,98],"against":[85],"calf":[86],"thymus":[87],"cytidine":[88,114],"reductase.":[90],"5-Fluorouracil":[91],"derivative":[92,115],"is":[94,108,117],"nearly":[95],"equipotent":[96],"inhibiting":[100],"growth":[102],"HeLa":[104],"cells,":[105],"1":[107],"a":[109],"much":[110],"weaker":[111],"inhibitor":[112],"devoid":[118],"activity":[120],"at":[121],"200":[122],"micrograms/mL.":[123]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1985337271","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2015,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
